Profitability
Weight: 20%
F
0
- 5yr Avg ROIC -22.8%
- Operating Margin Trend -2272.91 pp/yr
XENE
Xenon Pharmaceuticals Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 16.9 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -28.4%
- 5yr Share-Count CAGR 18.1%
Growth Quality
Weight: 15%
F
0
- 5yr Revenue CAGR -25.3%
- Revenue-Growth Years (5) 0/5
Cash Generation
Weight: 15%
F
0
- 5yr FCF Margin -1731.4%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 20%
C
55
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 6.21
Stability
Weight: 15%
D+
39
- Negative-Revenue Years (5) 2/5
- Piotroski F-Score 2
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 2 added.
- Holders
- 3
- Avg Δ position
- +794.7%
- New buys
- 0
- Full exits
- 0